BackAdverum Biotechnologies Overview

Adverum Biotechnologies EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ADVM.

Quarterly EBIT

-$47.65M
70.04% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

-$137.77M
23.89% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)